Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

498 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm.
Miyagawa K, Rösch J, Stanczyk F, Hermsmeyer K. Miyagawa K, et al. Nat Med. 1997 Mar;3(3):324-7. doi: 10.1038/nm0397-324. Nat Med. 1997. PMID: 9055861
Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys.
Mishra RG, Hermsmeyer RK, Miyagawa K, Sarrel P, Uchida B, Stanczyk FZ, Burry KA, Illingworth DR, Nordt FJ. Mishra RG, et al. Among authors: miyagawa k. J Clin Endocrinol Metab. 2005 Jun;90(6):3706-14. doi: 10.1210/jc.2004-1557. Epub 2005 Mar 15. J Clin Endocrinol Metab. 2005. PMID: 15769993 Free PMC article.
In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
Minshall RD, Miyagawa K, Chadwick CC, Novy MJ, Hermsmeyer K. Minshall RD, et al. Among authors: miyagawa k. FASEB J. 1998 Oct;12(13):1419-29. doi: 10.1096/fasebj.12.13.1419. FASEB J. 1998. PMID: 9761786
Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys.
Minshall RD, Stanczyk FZ, Miyagawa K, Uchida B, Axthelm M, Novy M, Hermsmeyer K. Minshall RD, et al. Among authors: miyagawa k. J Clin Endocrinol Metab. 1998 Feb;83(2):649-59. doi: 10.1210/jcem.83.2.4576. J Clin Endocrinol Metab. 1998. PMID: 9467588
Ca2+ release mechanism of primate drug-induced coronary vasospasm.
Miyagawa K, Vidgoff J, Hermsmeyer K. Miyagawa K, et al. Am J Physiol. 1997 Jun;272(6 Pt 2):H2645-54. doi: 10.1152/ajpheart.1997.272.6.H2645. Am J Physiol. 1997. PMID: 9227542
Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys.
Hermsmeyer K, Miyagawa K, Kelley ST, Rösch J, Hall AS, Axthelm MK, Greenberg B. Hermsmeyer K, et al. Among authors: miyagawa k. J Am Coll Cardiol. 1997 Mar 1;29(3):671-80. doi: 10.1016/s0735-1097(96)00524-4. J Am Coll Cardiol. 1997. PMID: 9060910
Protein kinase C mechanism enhances vascular muscle relaxation by the Ca2+ antagonist, Ro 40-5967.
Hermsmeyer K, Miyagawa K. Hermsmeyer K, et al. Among authors: miyagawa k. J Vasc Res. 1996 Jan-Feb;33(1):71-7. doi: 10.1159/000159134. J Vasc Res. 1996. PMID: 8603130
Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists.
Hermsmeyer K, Mishra S, Miyagawa K, Minshall R. Hermsmeyer K, et al. Among authors: miyagawa k. Clin Ther. 1997;19 Suppl A:18-26. doi: 10.1016/s0149-2918(97)80034-3. Clin Ther. 1997. PMID: 9385502 Review.
[Calcium kinetics and effects of calcium antagonist on vascular smooth muscle].
Aoki K, Miyagawa K. Aoki K, et al. Among authors: miyagawa k. Nihon Rinsho. 1989 Aug;47(8):1746-52. Nihon Rinsho. 1989. PMID: 2585737 Japanese. No abstract available.
Effects of mibefradil on intracellular Ca2+ release in cultured rat cardiac fibroblasts and human platelets.
Eberhard M, Miyagawa K, Hermsmeyer K, Erne P. Eberhard M, et al. Among authors: miyagawa k. Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):94-101. doi: 10.1007/BF00168921. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8750922
498 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback